Considering the molecular way, the BRAF mutation is more frequent in SSAs [14], which is rarely present in traditional adenomas; this supports the concept that the “serrated pathway” represents an alternative route to CRC [15]. This evidence concerns the gene BRAF and colorectal carcinoma.